How many insider trades does FilingIQ track for VBIO?

FilingIQ tracks 26 Form 4 insider transactions for VBIO (Valion Bio, Inc.), covering filings from Jul 15, 2016 onwards. 1 of those were filed in the last 90 days.

Are VBIO insiders net buyers or net sellers?

Across the full Form 4 history for VBIO, 17 transactions (65%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VBIO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VBIO in?

Valion Bio, Inc. (VBIO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.92M.

VBIO insider trading

NasdaqCM Healthcare

Valion Bio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

65% / 0%

Market cap

$1.92M

About Valion Bio, Inc.

Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its commercial product under the ClearUP Sinus Pain Relief brand name. It also focusses on non-invasive vagus nerve stimulation. The company was incorporated in 2016 and is based in Fremont, California.

Company website: tivichealth.com

VBIO insider activity at a glance

FilingIQ has scored 26 insider transactions for VBIO since Jul 15, 2016. The most recent filing in our index is dated May 1, 2026.

Across the full history, 17 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VBIO insider trades is 51.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VBIO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for VBIO?: FilingIQ tracks 26 Form 4 insider transactions for VBIO (Valion Bio, Inc.), covering filings from Jul 15, 2016 onwards. 1 of those were filed in the last 90 days.
Are VBIO insiders net buyers or net sellers?: Across the full Form 4 history for VBIO, 17 transactions (65%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VBIO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VBIO in?: Valion Bio, Inc. (VBIO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.92M.

Methodology & sources

Every VBIO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.